What are the most valued startups in the wearable technology market?
Download our beautiful pitch about the wearable technology market

In our wearable technology market deck, you will find everything you need to understand the market
The wearable technology market has become one of the clearest examples of how hardware, health data, AI interfaces, and recurring software models can combine into very large startup outcomes.
This ranking is a constantly refreshed list of the top startups in the wearable technology market, ranked by valuation and updated every month.
From smart rings and performance trackers to AR glasses, biosensor patches, neurotechnology devices, and medical monitoring wearables, the category is no longer just about consumer gadgets.
And if you want to better understand this new industry, you can download our pitch covering the wearable technology market.
A quick summary table
| Metric | Value |
|---|---|
| Most valuable wearable technology startup | Oura, estimated at $10.5B–$11.5B |
| Second most valuable wearable technology startup | WHOOP, valued at $10.1B |
| Median wearable startup valuation | Approximately $61M |
| Share of total wearable startup valuation captured by the top 10 | Approximately 72% |
| Top wearable startup valuation vs. median | Oura is about 180x the median startup valuation |
| Median valuation-to-capital-raised ratio in wearable technology | Approximately 3.1x |
| Wearable technology startups valued at $1B+ | 12 startups |

This market map, featured in our wearable technology market deck, highlights top companies and startups in the wearable technology market
Top startups in the wearable technology market ranked by valuation
Here is an updated table that ranks the top startups in the wearable technology market based on their latest reported or estimated valuations.
If you want more detaild about their fundraising activity, you can check our list of the startups who have raised the most funding in the wearable technology market.
| # | Startup Name | What They Do | Current Valuation ($) | Valuation Confidence Level | Valuation Type | Evidence Status | Total Funding ($) | Funding Confidence Level |
|---|---|---|---|---|---|---|---|---|
| 1 | Oura | Smart health tracking rings | $10.5B–$11.5B | Strong Confidence | IPO or Listing Range Valuation | Estimated | $1.2B | Strong Confidence |
| 2 | WHOOP | Performance subscription wearable tracker | $10.1B | Full Confidence | Announced Private Round Valuation | Observed | $979M | Strong Confidence |
| 3 | Magic Leap | Enterprise augmented reality headsets | $1.2B–$2.0B | Low Confidence | Proxy-Based Estimate | Estimated | $4.0B | Partial Confidence |
| 4 | BrainCo | Non-invasive BCI wearables | $1.3B–$1.6B | Partial Confidence | IPO or Listing Range Valuation | Estimated | $292M | Partial Confidence |
| 5 | XPANCEO | Smart AR contact lenses | $1.4B | Full Confidence | Announced Private Round Valuation | Observed | $290M | Full Confidence |
| 6 | RayNeo | Consumer AR smart glasses | $1.0B–$1.8B | Partial Confidence | Implied Valuation from Raise | Implied | $143M | Partial Confidence |
| 7 | Nothing | Consumer electronics and wearables | $1.2B–$1.4B | Strong Confidence | Announced Private Round Valuation | Observed | $450M | Partial Confidence |
| 8 | boAt | Audio wearables and smartwatches | $1.0B–$1.4B | Partial Confidence | IPO or Listing Range Valuation | Estimated | $171M | Partial Confidence |
| 9 | XREAL | Consumer AR smart glasses | $1.0B–$1.2B | Strong Confidence | Announced Private Round Valuation | Observed | $433M | Partial Confidence |
| 10 | VITURE | XR gaming glasses | $700M–$1.3B | Partial Confidence | Implied Valuation from Raise | Implied | $222M | Partial Confidence |
| 11 | OrCam | Assistive AI vision wearables | $800M–$1.1B | Partial Confidence | Comparables-Based Estimate | Estimated | $131M | Strong Confidence |
| 12 | Biolinq | Metabolic biosensor patch | $650M–$1.1B | Partial Confidence | Implied Valuation from Raise | Implied | $273M | Strong Confidence |
| 13 | Mojo Vision | Micro-LED display platform | $550M–$950M | Partial Confidence | Implied Valuation from Raise | Implied | $341M | Partial Confidence |
| 14 | Wispr AI | Voice-first AI interface | $650M–$750M | Strong Confidence | Announced Private Round Valuation | Observed | $81M | Partial Confidence |
| 15 | Willow | Wearable breast pump systems | $450M–$750M | Partial Confidence | Implied Valuation from Raise | Implied | $228M | Partial Confidence |
| 16 | Rokid | AR and AI smart glasses | $450M–$650M | Low Confidence | Comparables-Based Estimate | Estimated | $575M | Low Confidence |
| 17 | Biobeat | Cuffless blood-pressure patch | $330M–$625M | Strong Confidence | Implied Valuation from Raise | Implied | $50M | Strong Confidence |
| 18 | Ultrahuman | Smart rings and metabolic tracking | $350M–$600M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $98M | Partial Confidence |
| 19 | Cala Health | Wearable tremor neuromodulation | $350M–$550M | Partial Confidence | Implied Valuation from Raise | Implied | $245M | Partial Confidence |
| 20 | Hilo | Cuffless blood-pressure wearable | $280M–$525M | Partial Confidence | Implied Valuation from Raise | Implied | $100M | Strong Confidence |
| 21 | VitalConnect | Wearable cardiac biosensor patch | $250M–$450M | Partial Confidence | Implied Valuation from Raise | Implied | $241M | Partial Confidence |
| 22 | DigiLens | AR waveguide display optics | $250M–$450M | Partial Confidence | Comparables-Based Estimate | Estimated | $135M | Partial Confidence |
| 23 | Epicore Biosystems | Sweat-sensing wearable biosensors | $210M–$400M | Strong Confidence | Implied Valuation from Raise | Implied | $44M | Strong Confidence |
| 24 | INMO | AI AR smart glasses | $270M–$290M | Strong Confidence | Announced Private Round Valuation | Observed | $70M | Low Confidence |
| 25 | IXI | Autofocus adaptive eyewear | $180M–$300M | Partial Confidence | Implied Valuation from Raise | Implied | $37M | Strong Confidence |
| 26 | Neurable | BCI headphone platform | $175M–$292M | Strong Confidence | Implied Valuation from Raise | Implied | $56M | Partial Confidence |
| 27 | Swave Photonics | Holographic AR display chips | $160M–$280M | Strong Confidence | Implied Valuation from Raise | Implied | $46M | Full Confidence |
| 28 | Xplora | Kids smartwatches and services | $190M–$215M | Strong Confidence | Public Market Cap | Observed | $25M | Strong Confidence |
| 29 | Varjo | Enterprise VR/XR headsets | $150M–$250M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $149M | Strong Confidence |
| 30 | Temple | Cerebral blood-flow wearable | $190M | Full Confidence | Announced Private Round Valuation | Observed | $54M | Strong Confidence |
| 31 | Lumus | AR waveguide optical displays | $140M–$240M | Partial Confidence | Comparables-Based Estimate | Estimated | $57M | Strong Confidence |
| 32 | Avegant | AR display light engines | $150M–$190M | Strong Confidence | Announced Private Round Valuation | Observed | $94M | Partial Confidence |
| 33 | Orpyx | Diabetic foot sensor insoles | $130M–$200M | Partial Confidence | Implied Valuation from Raise | Implied | $39M | Strong Confidence |
| 34 | Pimax | High-end VR headsets | $100M–$180M | Partial Confidence | Implied Valuation from Raise | Implied | $79M | Strong Confidence |
| 35 | Dispelix | AR waveguide displays | $90M–$180M | Partial Confidence | Acquisition Value | Estimated | $50M | Strong Confidence |
| 36 | Cardiosense | AI cardiac wearable platform | $90M–$160M | Partial Confidence | Comparables-Based Estimate | Estimated | $15M | Strong Confidence |
| 37 | Sightful | AR laptop workspace | $90M–$150M | Partial Confidence | Proxy-Based Estimate | Estimated | $61M | Full Confidence |
| 38 | Bellabeat | Women’s wellness wearables | $90M–$140M | Partial Confidence | Implied Valuation from Raise | Implied | $19M | Full Confidence |
| 39 | NextSense | EEG sleep earbuds | $80M–$133M | Strong Confidence | Implied Valuation from Raise | Implied | $35M | Partial Confidence |
| 40 | Playermaker | Soccer performance foot sensors | $80M–$120M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $50M | Partial Confidence |
| 41 | Sky Labs | Ring blood-pressure monitor | $75M–$115M | Partial Confidence | Comparables-Based Estimate | Estimated | $40M | Partial Confidence |
| 42 | Bragi | Hearable software platform | $70M–$110M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $22M | Strong Confidence |
| 43 | Cellid | AR waveguides and spatial engines | $70M–$110M | Partial Confidence | Implied Valuation from Raise | Implied | $42M | Partial Confidence |
| 44 | DPVR | VR headsets for enterprise | $60M–$110M | Low Confidence | Revenue or ARR Multiple Estimate | Estimated | $54M | Low Confidence |
| 45 | Ozlo | Sleep-focused smart earbuds | $60M–$100M | Partial Confidence | Implied Valuation from Raise | Implied | $22M | Full Confidence |
| 46 | PlayerData | Team GPS performance analytics | $60M–$100M | Partial Confidence | Implied Valuation from Raise | Implied | $14M | Partial Confidence |
| 47 | Mobvoi | Smartwatches and AI earbuds | $74M | Full Confidence | Public Market Cap | Observed | $233M | Strong Confidence |
| 48 | USound | MEMS speakers for wearables | $55M–$85M | Partial Confidence | Comparables-Based Estimate | Estimated | $74M | Partial Confidence |
| 49 | Brilliant Labs | AI-powered AR glasses | $35M–$70M | Partial Confidence | Comparables-Based Estimate | Estimated | $6M | Strong Confidence |
| 50 | NeoSensory | Sensory substitution wearables | $35M–$70M | Partial Confidence | Comparables-Based Estimate | Estimated | $16M | Strong Confidence |
| 51 | Flow Neuroscience | Depression stimulation headset | $35M–$70M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $12M | Strong Confidence |
| 52 | myFirst | Kids connected wearables | $40M–$65M | Strong Confidence | Implied Valuation from Raise | Implied | $8M | Strong Confidence |
| 53 | Shot Scope | Golf GPS shot tracking | $45M–$75M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $21M | Partial Confidence |
| 54 | MAD Gaze | Consumer AR smart glasses | $45M–$85M | Partial Confidence | Comparables-Based Estimate | Estimated | $32M | Strong Confidence |
| 55 | RingConn | Subscription-free smart rings | $50M–$85M | Low Confidence | Proxy-Based Estimate | Estimated | Not provided | Low Confidence |
| 56 | Solos | AI smart glasses | $20M–$50M | Low Confidence | Proxy-Based Estimate | Estimated | $0M | Low Confidence |
| 57 | AngelSense | Wearable GPS safety devices | $25M–$50M | Low Confidence | Revenue or ARR Multiple Estimate | Estimated | $0M | Low Confidence |
| 58 | Embr Labs | Thermal comfort wrist wearable | $25M–$55M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $11M | Partial Confidence |
| 59 | Carv | Digital ski coaching wearable | $30M–$60M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $11M | Partial Confidence |
| 60 | InteraXon | Muse EEG headbands | $30M–$60M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $39M | Partial Confidence |
| 61 | Luna Ring | AI health smart ring | $30M–$60M | Low Confidence | Proxy-Based Estimate | Estimated | Not provided | Low Confidence |
| 62 | Emteq Labs | Emotion-sensing smart glasses | $40M–$50M | Strong Confidence | Active Raise Valuation | Observed | $3M | Low Confidence |
| 63 | TickTalk Tech | Kids GPS smartwatches | $40M–$75M | Low Confidence | Proxy-Based Estimate | Estimated | $0M | Full Confidence |
| 64 | Cosmo Connected | Connected urban safety gear | $30M–$55M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $12M | Partial Confidence |
| 65 | Strive | Muscle-performance smart apparel | $25M–$45M | Partial Confidence | Comparables-Based Estimate | Estimated | $9M | Strong Confidence |
| 66 | Danu Sports | Smart socks movement analytics | $20M–$35M | Partial Confidence | Implied Valuation from Raise | Implied | $5M | Partial Confidence |
| 67 | .lumen | Blind-mobility smart glasses | $23M–$39M | Partial Confidence | Implied Valuation from Raise | Implied | $5M | Partial Confidence |
| 68 | Stryd | Running power footpod | $15M–$30M | Partial Confidence | Proxy-Based Estimate | Estimated | $1M | Strong Confidence |
| 69 | Nix Biosensors | Sweat hydration biosensor patch | $15M–$30M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $7M | Low Confidence |
| 70 | Clim8 | Thermoregulating smart clothing | $15M–$30M | Partial Confidence | Comparables-Based Estimate | Estimated | $4M | Strong Confidence |
| 71 | CardiacSense | Cardiac monitoring watch | $18M–$25M | Strong Confidence | Announced Private Round Valuation | Observed | $25M | Partial Confidence |
| 72 | Sensoria | Smart sensor fitness clothing | $12M–$25M | Low Confidence | Proxy-Based Estimate | Estimated | $6M | Partial Confidence |
| 73 | OMI | Open-source AI wearable | $9M–$16M | Partial Confidence | Implied Valuation from Raise | Implied | $2M | Full Confidence |
| 74 | NeoSapien | AI-native wearable ecosystem | $9M–$15M | Partial Confidence | Implied Valuation from Raise | Implied | $2M | Strong Confidence |
| 75 | Timekettle | Translation earbuds | $20M–$40M | Low Confidence | Proxy-Based Estimate | Estimated | $1M | Low Confidence |
| 76 | Spire Health | Respiratory RPM sensors | $20M–$50M | Low Confidence | Acquisition Value | Estimated | $48M | Strong Confidence |
| 77 | NeuroSky | EEG and ECG biosensors | $20M–$50M | Low Confidence | Revenue or ARR Multiple Estimate | Estimated | $19M | Partial Confidence |
| 78 | Pison | Neural gesture wristband | $25M–$45M | Partial Confidence | Implied Valuation from Raise | Implied | $18M | Partial Confidence |
| 79 | Hexoskin | Biometric smart health shirts | $21M–$35M | Partial Confidence | Implied Valuation from Raise | Implied | $7M | Strong Confidence |
| 80 | Shadow Creator | AR/MR head-mounted displays | $15M–$40M | Low Confidence | Acquisition Value | Estimated | $38M | Partial Confidence |
| 81 | Mira | Lightweight AR headsets | $20M–$60M | Low Confidence | Acquisition Value | Estimated | $17M | Partial Confidence |
| 82 | Soundbrenner | Wearable musician metronomes | $8M–$15M | Low Confidence | Revenue or ARR Multiple Estimate | Estimated | $2M | Partial Confidence |
| 83 | Lynx | Open mixed-reality headsets | $10M–$25M | Low Confidence | Comparables-Based Estimate | Estimated | $6M | Partial Confidence |
| 84 | Gabit | Health smart ring platform | $35M–$55M | Strong Confidence | Implied Valuation from Raise | Implied | $13M | Strong Confidence |
| 85 | Halo Neuroscience | Neurostimulation headset | $5M–$15M | Low Confidence | Acquisition Value | Estimated | $22M | Partial Confidence |
| 86 | Quell | Wearable pain-relief device | $9M | Partial Confidence | Acquisition Value | Observed | $0M | Low Confidence |
| 87 | Sonic Lamb | Immersive haptic headphones | $4M–$7M | Partial Confidence | Implied Valuation from Raise | Implied | $1M | Partial Confidence |
| 88 | Lucyd | Smart audio eyewear | $6M | Full Confidence | Public Market Cap | Observed | $13M | Partial Confidence |
| 89 | MyKronoz | Hybrid smartwatches | $5M–$12M | Low Confidence | Proxy-Based Estimate | Estimated | Not provided | Low Confidence |
| 90 | ThirdEye | Enterprise AR smart glasses | $5M–$15M | Low Confidence | Proxy-Based Estimate | Estimated | $0M | Low Confidence |
| 91 | deWiz | Golf swing wearable trainer | $1M–$5M | Low Confidence | Proxy-Based Estimate | Estimated | $9M | Partial Confidence |
| 92 | Circular | Smart health rings | $0M–$3M | Low Confidence | Proxy-Based Estimate | Estimated | Not provided | Low Confidence |
| 93 | RunScribe | Wearable gait analysis sensors | $1M–$4M | Low Confidence | Proxy-Based Estimate | Estimated | $0M | Low Confidence |
| 94 | NURVV | Running biomechanics smart insoles | $0M–$2M | Strong Confidence | Proxy-Based Estimate | Estimated | $9M | Strong Confidence |
| 95 | LAFORGE Optical | AR prescription smart glasses | $0M–$2M | Low Confidence | Proxy-Based Estimate | Estimated | $2M | Strong Confidence |

This chart, included in our wearable technology market deck, compares the 2026 size of the wearable technology market with other markets of similar size
Key valuation trends in the wearable technology market
Insights
- Oura and WHOOP together represent about $21.1B in wearable technology valuation, which shows how strongly investors reward health data platforms with recurring consumer engagement.
- The top 10 wearable technology startups capture roughly 72% of the total valuation in this list, so the market is highly concentrated around a few breakout platforms.
- Oura is worth about 180 times the median company in this wearable startup ranking, which highlights the gap between mainstream health platforms and niche hardware startups.
- Clinical-grade biosensing looks unusually capital efficient, with Biobeat and Epicore together reaching roughly $783M in combined midpoint valuation after raising only $94M.
- AR and XR wearables remain investable but fragmented, with companies such as Swave, Dispelix, Lumus, IXI, and Pimax still sitting below the billion-dollar threshold.
- Public wearable technology names remain much smaller than private category leaders, with Mobvoi and Xplora together valued far below Oura alone.
- The strongest wearable technology opportunities now sit where devices create defensible data layers, especially health signals, neurointerfaces, clinical monitoring, and AI-driven user interfaces.

This chart, included in our wearable technology market deck, shows why Whoop is leading in wearable technology
A few word about our methodology
As you can see, we built a database that ranks startups in the wearable technology market based on their current valuation.
Estimating startup valuations is not always straightforward. Many wearable technology companies do not publicly disclose their valuation, and the available information can vary widely depending on the company and its stage.
To build this ranking, we applied a structured valuation methodology and cross-checked information across multiple reliable sources.
Whenever possible, we relied on direct disclosures. These include announced valuations from completed funding rounds, public filings for listed companies, or official acquisition prices.
When a wearable technology startup is publicly listed, we use its current market capitalization as the reference valuation.
If a company was acquired and no independent valuation can reasonably be estimated today, we use the acquisition price as the main reference point.
When a startup recently raised capital but the valuation was not disclosed, we estimate the implied valuation using typical dilution levels for that stage of fundraising.
In some cases, we also estimate valuations using operating metrics such as revenue, ARR, subscription activity, device sales, clinical adoption, or customer traction, combined with valuation multiples from comparable companies in the same market.
When direct financial data is not available, we may rely on carefully selected comparable startups and other signals such as hiring growth, investor quality, product traction, regulatory progress, clinical validation, or hardware distribution.
All estimates follow a strict evidence hierarchy. Recent funding rounds with announced valuations carry the most weight, followed by strong operating metrics and comparable company analysis.
We also carefully evaluate the age of every data point. Recent information carries more weight, while older data is treated cautiously and adjusted conservatively when necessary.
Whenever information is uncertain or incomplete, we clearly distinguish between confirmed facts and reasonable inferences.
Because valuation data is not always fully public, each startup in the ranking is assigned a confidence level based on the reliability, recency, and consistency of the available evidence.
Full confidence means the valuation is supported by strong and recent evidence. Strong confidence means the estimate is well supported but includes minor inference. Partial confidence means the estimate relies more heavily on indirect signals. Low confidence means available information is limited or inconsistent.
When confidence is lower, we take a more conservative approach by widening the valuation range. This helps reflect the uncertainty and increases the probability that the true valuation falls within the estimated range.
This reflects how we conduct all our research, including the work behind our report covering the wearable technology market.
In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.
If you want the full detail on a specific valuation estimate, feel free to contact us and we will gladly explain.
Finally, know that we update the dataset once per month, so come back here if you need fresh information.

This chart, included in our wearable technology market deck, illustrates yearly funding for wearable technology startups
Related blog posts
- The latest news in the wearable technology market
- The most recent funding news in wearable technology
- The most recent developments in wearable technology
- The evolution of funding activity in wearable technology
- The main fundraising trends in wearable technology
Who is the author of this content?
NEW MARKET PITCH TEAM
We track new markets so founders and investors can move fasterWe build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.
How we created this content 🔎📝
At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.
So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.
Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.